jCyte is sponsoring a Phase 2b clinical trial to investigate our developmental stem cell therapy to treat retinitis pigmentosa (RP). This potentially groundbreaking approach is designed to preserve and potentially improve vision for patients with RP.

To assess the treatment’s safety and efficacy, jCyte has contracted with The Gavin Herbert Eye Institute (GHEI) at the University of California, Irvine, Retinal-Vitreous Associates Medical Group in Beverly Hills and Ophthalmic Consultants of Boston to conduct the clinical trial.

jCyte is no longer enrolling patients for the Phase 2b trial, however if you are interested in participating in potential future trials, please send an email to: info@jcyte.com